ACN vs CLDX · P/E 24, rev $17.60B vs rev $37.0K
Accenture plc (ACN) versus Celldex Therapeutics Inc (CLDX) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. CLDX currently screens at market cap $2.35B.
Not investment advice. Open the ACN and CLDX stock pages for the full models.
Not investment advice.